The Drug-Induced Respiratory Disease Website
XI. Pulmonary vasculopathies
XI.e Pulmonary artery aneurysm(s)
XII. Pericardial involvement
XII.c Hemopericardium - Bloody pericardial effusion
XIII. Thrombosis - Embolism
XIII.c Cement embolism
XIII. Thrombosis - Embolism
XIII.d Intracardiac bone cement embolism
XIII. Thrombosis - Embolism
XIII.f Fat/oil embolism - The FES embolism syndrome
XVII. Heart injury/trauma/perforation
XVII.a Perforation of the heart - Cardiac rupture
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXX. Imaging features
XXX.m Imaging: Foreign body pulmonary embolism
XXXI. Eye catchers
XXXI.b Eye-catcher: Cement (pulmonary) embolism
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.o Path: Lipid/fat embolism
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.w Path: Acrylate bone cement pulmonary embolism
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.o Rapidly progressive ILD/pulmonary fibrosis (Hamman-Rich syndrome)
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.c Sarcoid-like granulomatosis (endo-/extrathoracic)
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.b Atrial fibrillation
II. Myocardial dysfunction - Heart failure
II.a Left ventricular dysfunction/failure
III. Myocardial ischemia - Coronary artery disease
III.a Coronary artery disease (acute) - Myocardial ischemia/infarction
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
VI. Cardiomyopathy
VI.c Takotsubo (stress) cardiomyopathy
VIII. Valvular heart disease
VIII.a Valvular heart disease and/or dysfunction
XI. Pulmonary vasculopathies
XI.a Pulmonary arterial hypertension
XI. Pulmonary vasculopathies
XI.i Pulmonary veno-occlusive disease
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XXVI. Neuromuscular dysfunction
XXVI.a Phrenic nerve injury - Hemi- or bilateral diaphragmatic paralysis
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)
XXXVIII. Miscellaneous - Varia
XXXVIII.k Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)
X. Pulmonary edema
X.b Pulmonary edema, noncardiogenic (NCPE)
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.k Pulmonary infiltrates
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.ag Chemical (toxic) pneumonitis
XXVIII. Large airway involvement
XXVIII.b Epiglottitis
XXVIII. Large airway involvement
XXVIII.c Tracheal injury
XXIX. Small airway involvement
XXIX.l Bronchiolitis (a clinical-imaging pattern suggestive of)
XXIX. Small airway involvement
XXIX.m Obstructive airway dysfunction (see also IVc, XVx)
XXIX. Small airway involvement
XXIX.n Reactive airway dysfunction syndrome (RADS)
XXX. Imaging features
XXX.k Imaging: Centrilobular micronodules (can be diffuse)
XXX. Imaging features
XXX.n Imaging: A 'tree-in-bud' pattern
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.j Path: Pulmonary edema
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.r Anti-GBM-related pneumorenal syndrome and DAH (Goodpasture) or flare of
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.g QTc prolongation
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.l Cardiac- cardiorespiratory/pulmonary arrest
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.n Respiratory arrest - Apnea
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
V. Myocarditis
V.b Eosinophilic myocarditis
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
XII. Pericardial involvement
XII.g Pleural/pericardial effusion, ANA positive (DI lupus)
XIII. Thrombosis - Embolism
XIII.a Pulmonary embolism - Venous thrombosis/thrombo-embolism
XXII. Acute respiratory/cardiorespiratory failure
XXII.e Respiratory failure from ventilatory depression (of neuromuscular cause or causes)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXVI. Neuromuscular dysfunction
XXVI.e Respiratory dyskinesia
XXVIII. Large airway involvement
XXVIII.f Laryngospasm (a.k.a. laryngismus)
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.b Lupus - Lupus syndrome
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)
XXXVIII. Miscellaneous - Varia
XXXVIII.c Antiphospholipid antibodies w/wo the APL syndrome